← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2017Last known activity
Nov 30, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT06069336Lead sponsorN/ANov 30, 2023
- NCT06069336Reponsible party - principal investigatorN/ANov 30, 2023
- NCT03592485CollaboratorPhase 4Jun 28, 2018
- NCT02989350Reponsible party - principal investigatorPhase 2/Phase 3Jan 1, 2017
- NCT02989350Lead sponsorPhase 2/Phase 3Jan 1, 2017
Details
- Last known activity
- Nov 30, 2023